IonQ DARPA Stage C: $300M Is the Program’s Published Cap

By Stock Titan Editorial Team · Published October 7, 2026

News Analysis IonQ DARPA Quantum computing Quantum Benchmarking Initiative IBM

IonQ’s October 7 announcement after the close

IonQ (NYSE: IONQ) said at 5:45 PM ET on October 7, 2026 that it had advanced to Stage C of the Defense Advanced Research Projects Agency’s Quantum Benchmarking Initiative, or QBI, and that IonQ and DARPA “have signed a Stage C agreement with a potential value of up to $300 million.” If you only read one more sentence of the release, it would be the next one: “Funding beyond the initial obligation remains subject to future appropriations and DARPA funding actions.”

The release only describes the work in broad terms. Stage C runs through 2029, and during it “multiple Superion generations” will go through DARPA’s independent verification and validation process, with DARPA’s team set to “rigorously test IonQ’s scalable hardware and software to demonstrate performance against its technical roadmap.” IonQ says it shared prototype hardware data with DARPA in Stages A and B, defined the technical concept for a utility-scale machine in Stage A, and produced a detailed research and development roadmap (with designs and risk-mitigation plans) in Stage B.

What the release leaves out is the size of the initial obligation, the payment schedule and the specific milestones. When we checked on the evening of October 7, IonQ had not filed an 8-K about the agreement on EDGAR, where its latest 8-K was dated September 8.

The committed amount behind the $300 million ceiling

IonQ’s release does not say how much DARPA has committed so far, and we found no figure in an 8-K or in IonQ’s other releases as of October 7. The release mentions an “initial obligation” but not its size, and it ties everything above that amount to appropriations (the spending Congress approves) and to later DARPA decisions. So the $300 million is a ceiling on what the agreement could be worth, and the part that is committed is an amount the release leaves out.

The ceiling figure also appears in DARPA’s own planning material. The Proposers Day presentation of September 3, 2024 lists the money per stage as up to $1 million for the six-month Stage A, up to $15 million for the 12-month Stage B and up to $300 million for Stage C, each with an asterisk pointing to the solicitation for “details and conditions,” and a DARPA briefing dated July 25, 2025 shows the same three figures. IonQ’s “up to $300 million” therefore matches the Stage C maximum in the program’s published plan, although the terms each company actually signed are not public.

The other Stage C companies show how differently the money can be described. Diraq, a silicon-qubit developer, announced “funding of up to US$300 million” and added that “an initial US$51 million funding tranche will support the next year,” which is 17% of its ceiling. PsiQuantum, which entered the final stage earlier through DARPA’s pilot program, announced a $31.8 million agreement in September 2025 and then, on July 22, 2026, a “$125 million expanded agreement,” according to its release, which does not say whether the larger amount adds to the earlier one or replaces it.

None of that tells you IonQ’s number. Diraq’s tranche and PsiQuantum’s agreements are separate announcements that measure different things (a first-year tranche in one case, agreement values in the other), and applying Diraq’s 17% to IonQ would be a guess.

The tests Superion systems face at DARPA through 2029

DARPA’s test in Stage C is whether a company’s planned utility-scale quantum computer “can be constructed as designed and operated as intended,” in the wording of the QBI program page. Utility scale has a specific meaning here: a machine whose computational value exceeds its cost, with 2033 as the year the program asks about.

DARPA’s Proposers Day presentation lists four things the agency wants out of Stage C. It wants to evaluate how a company finalizes the design of its full-size system, to test components and hardware directly, to assess how major prototypes perform at the system level, and, where it makes sense, to work with the company on applications and algorithms. The length is “a variable period of performance tailored to a specific performer’s R&D plan,” which DARPA assumed would be “nominally 36 months” when it estimated costs, and IonQ’s 2029 end date falls roughly inside that window.

DARPA decides when a company is ready. The same presentation says the companies that complete Stage C “will be those that DARPA deems are ready to immediately begin the final design and construction” of a utility-scale machine, and the Q&A is blunter about the limits of the money, saying “we do not anticipate that Stage C will build a USQC” and that any government involvement after Stage C “would transition from DARPA to other partners.” Completing Stage C would mean DARPA judged IonQ ready for the final design and construction of a utility-scale machine, and it would not by itself show a finished utility-scale computer.

Show the data

Date	Event
April 2025	IonQ selected for Stage A, the six-month concept stage.
November 2025	IonQ advances to Stage B, the year-long R&D plan review.
October 2026	IonQ signs a Stage C agreement worth up to $300M.
2027 target	IonQ targets Superion 256 deliveries and lab fault tolerance with on-chip CMOS.
2028 target	IonQ targets manufacturable, commercial CMOS integration.
Through 2029	Stage C testing of several Superion generations ends, per IonQ.
2033 goal	DARPA’s QBI asks whether any machine can be worth more than it costs by 2033.

For IonQ, the hardware DARPA will see is the Superion line. In its September 8 launch release, IonQ said it had fabricated its first 256-qubit chips and trapped the first ions in prototype Superion 256 systems, that Superion 256 is available to order with customer deliveries in 2027, and that a Superion 10K generation is being developed at the same time with CMOS circuitry integrated onto the chip, an integration that “is expected to reach full fault tolerance reality in a 2027 lab setting at IonQ, and manufacturable, commercial reality in 2028.” The chips and trapped ions are what IonQ says it has done, while the 2027 and 2028 dates are its own targets, which give outside observers something to compare against between now and 2029.

You will not find an acceptance criterion in the October 7 release (it names no qubit count, error rate, delivery quantity or test site). Those details could be in the agreement, which IonQ and DARPA have not published.

The companies that have reached Stage C

Five companies are known to be in QBI’s final stage, and they got there by two different routes. DARPA has not posted a Stage C roster for the October selections on its QBI pages as of this writing, so the table below comes from the companies’ own announcements plus DARPA’s earlier statements.

Microsoft and PsiQuantum came in through the Underexplored Systems for Utility-Scale Quantum Computing program, a pilot that DARPA expanded into QBI. DARPA said on February 6, 2025 that it had selected both and was in negotiations with them for the final phase, which has “the same technical goals as the final stage of QBI,” and in March 2026 DARPA still described two performers in Stage C. Microsoft wrote on September 22, 2026 that it is providing Majorana 2 hardware “for independent testing and evaluation” by DARPA at its Maryland research center, without stating an amount.

Three companies from the QBI track announced Stage C in the same news cycle: IBM at 5:30 PM ET and IonQ at 5:45 PM ET on October 7, plus Diraq in a release dated October 8 in Sydney. IBM gave no dollar figure, and its research director Jay Gambetta said “IBM expects to deliver the first fault-tolerant system in 2029.” Diraq said it aims to reach utility scale by 2031.

All three were among the 11 companies on DARPA’s Stage B list of November 6, 2025. The other eight were Atom Computing, Nord Quantique, Photonic Inc., Quantinuum, Quantum Motion, QuEra Computing, Silicon Quantum Computing and Xanadu, and we found no Stage C announcement from any of them by the evening of October 7. DARPA’s own page warns against reading too much into timing, since companies “have entered the evaluation process on varying timelines, resulting in staggered advancement,” and it says “multiple, single, or even no participants” may end up showing a path to a useful machine.

The $300 million ceiling next to IonQ’s own numbers

The full ceiling is roughly equal to IonQ’s reported GAAP research and development expense for the first half of 2026. IonQ’s second-quarter 10-Q shows GAAP R&D expense of $286.4 million for the first half of 2026, $116.3 million of it stock-based compensation, which puts $300 million at about 1.05 times the reported expense and about 1.8 times the $170.0 million left once stock pay is taken out. If you spread the ceiling evenly over DARPA’s nominal 36 months you would get about $100 million a year (that is only arithmetic, since no payment schedule has been published), and IonQ’s GAAP R&D expense in the second quarter alone was $160.6 million.

Show the data

Category	Value
Stage C ceiling, multi-year	$300.0M
R&D expense (GAAP), H1 2026	$286.4M
Operating cash used, H1 2026	$254.8M
Revenue, H1 2026	$144.7M

On the revenue side, IonQ reported $144.7 million for the first half of 2026 and $80.1 million for the second quarter, and in its August 5 results release it raised its full-year 2026 revenue outlook to between $280 million and $290 million. The same release put cash, cash equivalents and investments at $3.0 billion on June 30, 2026, or $2.0 billion pro forma for the SkyWater acquisition, which makes the $300 million ceiling about 15% of the pro forma figure. Net cash used in operating activities was $254.8 million in the first half, per the 10-Q.

The 10-Q has one more reference point, the roughly $485.0 million of remaining performance obligations IonQ reported at June 30, 2026. By IonQ’s definition that counts funded orders and also “unfunded (firm orders for which funding has not been appropriated)” orders, and it excludes unexercised options. The agreement was announced after the third quarter ended on September 30, so it may not show up in that quarter’s figure at all, and a later filing may or may not break out its effect.

IonQ shares around its earlier QBI news

The October 7 release came after the regular session had ended. IonQ closed that day at $41.34, down 4.50% from $43.29 on October 6, according to StockTitan’s daily price data, so the close reflects nothing in the announcement. Our explainer on releases before the open and after the close covers why the next session is where such news usually shows up.

IonQ’s Stage B release went out in the same 5:45 PM ET slot on November 6, 2025. In StockTitan’s price data the stock closed at $57.43 that day, opened the next session at $54.62 (4.89% lower) and closed it at $59.27, up 3.20%. That reading is muddied, because IonQ had published its third-quarter 2025 results after the close on November 5, so two pieces of news were trading at once. The Stage A selection in April 2025 came out during market hours, so its effect cannot be separated from the rest of that session’s trading. The price history on the IonQ overview page and the stock return calculator let you line up any of these dates yourself.

Disclosures that would fill the gaps

The size of the initial obligation is the number we would look for first (an 8-K or a later quarterly report could carry it, and our guides to SEC filing types and to reading a 10-Q show where such amounts tend to sit). Comparing it with Diraq’s $51 million first-year tranche would only work if IonQ also said what period, work and funding terms its first amount covers.

We would read funding news and hardware news separately. Each new tranche depends on appropriations and on DARPA’s decisions, so a follow-on amount would say the money is still coming, while a long gap between announcements could be a budget matter or just a company that chose to say little. On the hardware you would look for disclosed test results or milestones, measured against IonQ’s own dates (Superion 256 deliveries to customers in 2027, and lab fault tolerance from integrated CMOS the same year).

A DARPA list of Stage C companies would settle who is in the final stage, and further promotions from the eight remaining Stage B firms would show how widely companies are advancing. IonQ’s filings and releases are on its StockTitan news page, and its reported numbers are on the financials page.

Frequently asked questions

The information provided in this article is for educational and informational purposes only. It does not constitute financial advice, investment recommendation, or an endorsement of any particular investment strategy. Past performance does not guarantee future results. Investors should conduct their own research and consult with a qualified financial advisor before making investment decisions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now